These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 24330860

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: a randomized, double-blind, placebo- and active-controlled trial.
    Loebel A, Cucchiaro J, Sarma K, Xu L, Hsu C, Kalali AH, Pikalov A, Potkin SG.
    Schizophr Res; 2013 Apr; 145(1-3):101-9. PubMed ID: 23415311
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of lurasidone dose on cognition in patients with schizophrenia: post-hoc analysis of a long-term, double-blind continuation study.
    Harvey PD, Siu CO, Ogasa M, Loebel A.
    Schizophr Res; 2015 Aug; 166(1-3):334-8. PubMed ID: 26117157
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial.
    Findling RL, Pathak S, Earley WR, Liu S, DelBello MP.
    J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):325-35. PubMed ID: 24956042
    [Abstract] [Full Text] [Related]

  • 10. Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study.
    Meltzer HY, Cucchiaro J, Silva R, Ogasa M, Phillips D, Xu J, Kalali AH, Schweizer E, Pikalov A, Loebel A.
    Am J Psychiatry; 2011 Sep; 168(9):957-67. PubMed ID: 21676992
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study.
    Nasrallah HA, Silva R, Phillips D, Cucchiaro J, Hsu J, Xu J, Loebel A.
    J Psychiatr Res; 2013 May; 47(5):670-7. PubMed ID: 23421963
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study.
    Kahn RS, Schulz SC, Palazov VD, Reyes EB, Brecher M, Svensson O, Andersson HM, Meulien D, Study 132 Investigators.
    J Clin Psychiatry; 2007 Jun; 68(6):832-42. PubMed ID: 17592906
    [Abstract] [Full Text] [Related]

  • 17. Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study.
    Weisler R, Joyce M, McGill L, Lazarus A, Szamosi J, Eriksson H, Moonstone Study Group.
    CNS Spectr; 2009 Jun; 14(6):299-313. PubMed ID: 19668121
    [Abstract] [Full Text] [Related]

  • 18. Association of C-reactive protein and metabolic risk with cognitive effects of lurasidone in patients with schizophrenia.
    Miller BJ, Pikalov A, Siu CO, Tocco M, Tsai J, Harvey PD, Newcomer JW, Loebel A.
    Compr Psychiatry; 2020 Oct; 102():152195. PubMed ID: 32896775
    [Abstract] [Full Text] [Related]

  • 19. Insight and Treatment Outcomes in Schizophrenia: Post-hoc Analysis of a Long-term, Double-blind Study Comparing Lurasidone and Quetiapine XR.
    Harvey PD, Siu CO, Loebel AD.
    Innov Clin Neurosci; 2017 Dec 01; 14(11-12):23-29. PubMed ID: 29410934
    [Abstract] [Full Text] [Related]

  • 20. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.
    El-Khalili N, Joyce M, Atkinson S, Buynak RJ, Datto C, Lindgren P, Eriksson H.
    Int J Neuropsychopharmacol; 2010 Aug 01; 13(7):917-32. PubMed ID: 20175941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.